Toward clinically actionable lupus biomarkers: a roadmap for research, validation and translation

Authors:
Publisher website
Google Scholar
Abstract
Despite advances in lupus biomarker research, clinical translation has remained limited, leading to delayed diagnosis, imprecise disease monitoring and trial-and-error treatment approaches. This roadmap, developed by the Lupus Research Alliance’s Biomarker Roadmap Committee with input from patients and experts, identifies key priorities for translating research into clinical benefit. Three major clinical unmet needs are highlighted: improving diagnostic accuracy of SLE and neuropsychiatric SLE, developing sensitive longitudinal markers for disease activity (including LN), and predicting disease progression and treatment response. We review the current state of biomarker development across these domains and highlight barriers that hinder clinical validation, assay development and clinical adoption. We propose focused strategies to overcome these challenges, emphasizing analytically validated assays, diverse longitudinal cohorts, alignment with meaningful clinical outcomes and consortium-based efforts. The roadmap outlines a path to transform lupus diagnosis, monitoring and precision medicine, enabling research advances to improve patient care.
Funding Information
  • Lupus Research Alliance on a voluntary basis

This publication has 145 references indexed in Scilit: